2025-06-16-花旗集团-A2牛奶公司（A2M）_A2牛奶公司（A2M.AX）_来自中国的更多积极信号_10页_335kb

Citi Research | A2 Milk (A2M.AX) - June 2025 Analysis

Citigroup Take

A2M may benefit from near-medium-term prospects due to

1. China's Extended Marriage Leave: This policy change potentially boosts birth rates and supports infant formula companies, including A2M.
2. Strong Demand Signal: A major infant formula ingredient supplier (Clover Corp.) significantly beat expectations, reflecting robust market demand, although A2M's guidance exceedance might face supply constraints.

Target Price & Valuation

• Target Price: A$8.20 (up from A$7.91)
• Expected Share Price Return: 3.7%
• Expected Dividend Yield: 2.3%
• Expected Total Return: 6.0%
• Valuation Methods:
  • PE Relative Valuation: A$10.92
  • DCF Valuation: A$5.36
  • Sum-of-Parts Valuation: A$6.59
• A2M trades at a 70% premium to the ASX 200 Industrials multiple.

Risks

Upside Risks:

1. Global consolidation
2. Faster-than-expected reduction in Chinese market volatility
3. Legal uncertainty around functional benefits resolved
4. Faster new market penetration

Downside Risks:

1. Failure to comply with food safety/quality standards
2. Negative info regarding A1 Protein Free milk
3. IP expiry/weakening/infringement
4. Competitor product/brand erosion
5. Reliance on third parties
6. Licence renewal difficulties
7. High customer concentration worsening profit margins